MENS MENS
Company Profile ↓Company Overview
MENS (MENS) is a publicly traded company listed on with a market capitalization of $155.86M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 18.8%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 18.6%.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -93.59% |
| 6 Months: | -6.39% |
| 3 Months: | -0.97% |
| 1 Month: | -4.65% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)43.00 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 96.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 2.83M | 2.80M | 2.06M | 2.61M |
| Operating Income | - | -2.83M | -2.80M | -2.06M | -2.61M |
| EBITDA | - | -5.74M | -3.52M | -1.86M | -2.03M |
| Interest Expense | - | 765.00K | 757.00K | 1.03M | 2.54M |
| Pretax Income | - | -6.63M | -4.40M | -3.02M | -4.67M |
| Tax Provision | - | 0 | 0 | 0 | 0 |
| Net Income | - | -6.63M | -4.40M | -3.02M | -4.67M |
| Diluted EPS | -0.06 | -0.09 | -0.06 | -0.04 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 8.74M | 8.25M | 6.37M | 20.78M |
| Current Assets | - | 2.46M | 1.84M | 206.00K | 15.54M |
| Cash & Equivalents | - | 718.00K | 177.00K | 98.00K | 1.18M |
| Inventory | - | - | - | - | - |
| Receivables | - | - | - | 0 | 13.51M |
| Total Liabilities | - | 38.38M | 42.32M | 42.88M | 45.68M |
| Current Liabilities | - | 12.91M | 14.26M | 12.13M | 34.81M |
| Long Term Debt | - | 6.32M | 8.52M | 10.68M | 10.16M |
| Total Debt | - | 14.25M | 16.69M | 18.14M | 18.55M |
| Total Equity | - | -29.63M | -34.07M | -36.52M | -24.91M |
| Shares Outstanding | - | 76.03M | 76.03M | 76.03M | 76.03M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -2.97M | -2.60M | -3.62M | -3.04M |
| Investing Cash Flow | - | 1.39M | 95.00K | 0 | -13.51M |
| Financing Cash Flow | - | 3.33M | 2.03M | 1.99M | 17.63M |
| Capital Expenditure | -137.00K | -246.00K | - | - | - |
| Free Cash Flow | - | -3.22M | -2.60M | -3.62M | -3.04M |
| Net Change in Cash | - | 1.75M | -478.00K | -1.63M | 1.08M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | 22.4% | 12.9% | 8.3% | 18.8% |
| ROCE % | - | 68.0% | 46.5% | 35.7% | 18.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MENS
2026-27 Men's Golf Schedule Now Available - gocolumbialions.com
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOdTZKUXJuUlZJQ0wwd0lRcndNLTF4bUM1YjBldWQ2SFA0UlFlNG9vZzJoNkx0T0o1VXRKX0xhWmJWOGNuTUI3UXJYVXA2SXFXZC1raEpiSnh3Q0VUTjhDdG1TSk9EOGIyWk9zZWZFMzRSNzNhQVNLVmtoQ2RWMl96T2NUTldGdXB3dUw4UT…
Benign prostatic hyperplasia patients projected to reach 150M-156M by 2035 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPRTQzeDhxTXBHMDJYbkJOUUFrbXdjbm93Y3FwNzdxWTcxajdmM0VkMzc2NjZ1d0NMWnA5S25UazluR1hZS25RMXpTZWJnbW9CQlBkTEpkN2V6bmdqS2ZnMDhlUEhZcmFISzdDQWdjQTZCYmhUR19oTzBxeHQtMlY1eEV2X1pPc213NlRYMH…
Luke Stock Earns Big Ten Men's Golfer of the Week Award - USC Athletics
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPaXJ0MGJNR3BpRXhYSDdtS2FrbjY4ZWJrMXExZE5OcHVKaTJreVRCendPcHFEb0hyUUtDLWZaRXZIeTQxd2puS0JyYWQ4aU1ZdUZ1QWZwdWlBeUdvbGdTVWRZemdnOGdjTTB4NU1WcDc2MGtKR1Z2Y2lETlBLM3Btc1JBdXR4ZmxSU3hFb0…
Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 36.2% in June - MarketBeat
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNaHJxT3h0WFdGZUgxbktsMVczUUFsZ0x0TGNGMlpBbWtTZ19iN0k0VGxvc3JLRm00MUs5aVMyeDZFdEFyTFVfUGM1MktybmRrQjRoNWE5cHl1dkk3SVQtSlFJN1NzXzJJVlFfRERxNlFhQUMxTm1WQm5nWkw1MExQZlVELWg1VmdHUzkxVW…
Draft stock watch: Analyzing top hitter performances at Men's College World Series - MLB.com
<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE1MeHo0bjZuWGNFUDZnYktISXVQeUVzWDQzSkJUSVlNa1U0dVk2ajR2N2NQLXdSR29lLUlRcUFIRWJPYkQ4cDRnNy1kU0ZMNXQxZDRBVnh3OFZRV3RMRkEtMHE1SkI3TFd4ZUR2UzNwTTJyQmtt0gGAAUFVX3lxTE5taGtLMEdFcXZYX0NaWV…
These men’s summer pajamas keep you incredibly cool - The Mercury News
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNRXJtbnhIc010LXNwYk9HNndnT3AyTXRYbVEtZjJBNGNLbDFXR3Iwd2FvaDY1T2tJU0RNaGljd0Yzak50ZDVrc0piemF4NF8tVmhrSlhnNkxISHVqeXZweFE5aTNERDVSS0RRU1dodkNpYVRvVlF0MkY5YnZjak55R1dxcHVDb1JrNXE1cT…
MENS — Frequently Asked Questions
What is the current share price of MENS?
As of 2026-08-05 17:25 PDT, MENS trades at $2.05 on NASDAQ/NYSE. Its 52-week range is $1.46 to $65.62.
What is the market capitalisation of MENS?
MENS has a market capitalisation of $155.86M on NASDAQ/NYSE.
What is the P/E ratio of MENS?
MENS trades at a trailing price-to-earnings (P/E) ratio of -51.63. Its price-to-book (P/B) ratio is -6.26.
What is the return on equity (ROE) of MENS?
MENS has a return on equity (ROE) of 18.75%. Its return on capital employed (ROCE) is 18.58%.
Is MENS a good stock to buy?
This page provides a data-driven analysis of MENS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.